Where does Adam Goulburn work?

Adam Goulburn is Managing Partner at Dimension Capital and Board director at Eikon Therapeutics and Board director at CareGuardian and Board director at Authorea.

What check size does Adam Goulburn write?

Adam Goulburn typically writes checks of $1M – $10M.

What boards does Adam Goulburn sit on?

Adam Goulburn holds tracked board seats at 3Scan, Authorea, CareGuardian, Drone Racing League, Variant Bio.

Where did Adam Goulburn go to school?

Adam Goulburn studied at Monash University (PhD, Stem Cell Research); UNSW (Bachelor of Commerce / Bachelor of Science, International Business).

Adam Goulburn

Investor

Managing Partner at Dimension Capital · Board director at Eikon Therapeutics · Board director at CareGuardian · Board director at Authorea

New York, New York

Writes $1M – $10M checks · typically $2M

About

Adam Goulburn, a PhD neuroscientist-turned-investor who founded or incubated Cajal Neuroscience and Kallyope, takes operational roles to build technically ambitious, biology-digitization ventures (microbiome, brain-computer interfaces, patient-accelerated drug development).

Contact· self-published, not guessed

a•••@dimensioncap.comreveal

Invests in

AI & Machine LearningBiotechData & InfrastructureRoboticsSaaS

Board director at Eikon Therapeutics

Intro paths

→

In turn, Adam can intro founders to Eikon Therapeutics's investors below.

Eikon Therapeutics's investors · 3

Dimension CapitalSan Francisco · $1M – $10M checks · since 2022 Foresite CapitalWest Hollywood · since 2025 Lux CapitalNew York · $100K – $100M checks

Board director at CareGuardian

Intro paths

→

In turn, Adam can intro founders to CareGuardian's investors below.

CareGuardian's investors · 1

Dimension CapitalSan Francisco · $1M – $10M checks · since 2015

Board director at Authorea

Intro paths

→

In turn, Adam can intro founders to Authorea's investors below.

Authorea's investors · 3

Bloomberg BetaSan Francisco · $25K – $1M checks · since 2015 Dimension CapitalSan Francisco · $1M – $10M checks · since 2015 New York Venture PartnersNew York · $25K checks · since 2015

Co-founders at Authorea

Nathan JenkinsExecutive Officer

Alberto PepeExecutive Officer, Director

Experience

DimensionCo-Foundercurrent2022 — presentNew York
Lux CapitalVenture Partner2022
Lux CapitalPartner2015 — 2022
Lux CapitalPrincipal2014 — 2015New York City Metropolitan Area
Lux CapitalSenior Associate2012 — 2014New York City Metropolitan Area
Lux CapitalAssociate2011 — 2012New York
VNV Bio (now Aera Therapeutics)Founding CEO2018 — 2021New York, United States
KallyopeFounding CEO2014 — 2015New York
Weill Cornell Medical CollegePost-Doctoral Associate2010 — 2011New York

Skills & more

Venture Capital35Lifesciences8Entrepreneurship25Regenerative Medicine4Biotechnology28Commercialization15Start-ups40Digital Health7

From Adam's professional profile.

Deals · 5

Variant BioBoard seat

via Dimension Capital · filed Oct 2019 · $31.5M raise

Drone Racing LeagueBoard seat

via Dimension Capital · filed Jun 2019 · $50M raise

3ScanBoard seat

via Dimension Capital · filed Jul 2016 · $14M raise

AuthoreaBoard seat

via Dimension Capital · filed Jan 2016 · $1.5M raise

press ↗

CareGuardianBoard seat

via Dimension Capital · filed Jan 2016 · $30.3M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Dimension Capital

Alana Green

Investor at Dimension Capital

Amy Zhen

Investor at Dimension Capital

Anna Bitton

CFO at Torch Capital

AnneMarie Bott

Investor at Dimension Capital

Bauer LeSavage

Research Associate at Dimension Capital

Chris Gibson

Portfolio Director, Private Equity at Bridges Fund Management Ltd.

Frank Gao

Investor at Dimension Capital

Nan Li

Founder and Managing Partner at Dimension Capital

Network10

Anarghya VardhanaScout

General Partner at Maveron

Chris GibsonScout

Portfolio Director, Private Equity at Bridges Fund Management Ltd.

Josh WolfeScout

Partner and Co-Founder at Lux Capital

Nitesh BantaScout

Co-founder and Advisor at Rough Draft Ventures

Pablo LubrothScout

Investor at Future Planet Capital

Chad Packard

Partner at Pelion Venture Partners

Elena Viboch

Managing Director at General Catalyst

Larry Lasky

Partner at The Column Group

Leon Chen

Partner at The Column Group

Zavain Dar

Founder and Managing Partner at Dimension Capital

Investors connected to Adam in public investor directories — a warm-intro map.

Frequently asked questions

Who is Adam Goulburn?: Adam Goulburn, a PhD neuroscientist-turned-investor who founded or incubated Cajal Neuroscience and Kallyope, takes operational roles to build technically ambitious, biology-digitization ventures (microbiome, brain-computer interfaces, patient-accelerated drug development).
Where does Adam Goulburn work?: Adam Goulburn is Managing Partner at Dimension Capital and Board director at Eikon Therapeutics and Board director at CareGuardian and Board director at Authorea.
What does Adam Goulburn invest in?: Adam Goulburn invests in AI & Machine Learning, Biotech, Data & Infrastructure, Robotics, SaaS.
What check size does Adam Goulburn write?: Adam Goulburn typically writes checks of $1M – $10M.
What boards does Adam Goulburn sit on?: Adam Goulburn holds tracked board seats at 3Scan, Authorea, CareGuardian, Drone Racing League, Variant Bio.
Where did Adam Goulburn go to school?: Adam Goulburn studied at Monash University (PhD, Stem Cell Research); UNSW (Bachelor of Commerce / Bachelor of Science, International Business).